CYCLACILLIN Drug Patent Profile
✉ Email this page to a colleague
When do Cyclacillin patents expire, and what generic alternatives are available?
Cyclacillin is a drug marketed by Teva and is included in one NDA.
The generic ingredient in CYCLACILLIN is cyclacillin. There are two drug master file entries for this compound. Additional details are available on the cyclacillin profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CYCLACILLIN?
- What are the global sales for CYCLACILLIN?
- What is Average Wholesale Price for CYCLACILLIN?
Summary for CYCLACILLIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 26 |
Patent Applications: | 3,675 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CYCLACILLIN at DailyMed |
![CYCLACILLIN drug patent expirations Drug patent expirations by year for CYCLACILLIN](/p/graph/s/t/CYCLACILLIN-patent-expirations.png)
Medical Subject Heading (MeSH) Categories for CYCLACILLIN
US Patents and Regulatory Information for CYCLACILLIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Teva | CYCLACILLIN | cyclacillin | TABLET;ORAL | 062895-001 | Aug 4, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Teva | CYCLACILLIN | cyclacillin | TABLET;ORAL | 062895-002 | Aug 4, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |